Industri

Agilent Technologies inaugurates India Refurbishment Ce...

Agilent Technologies, a global leader in life sciences, diagnostics, and applie...

AstraZeneca announces new phase III clinical data for b...

AstraZeneca announced new Phase III clinical data for baxdrostat, an investigat...

IDMA PAC 2025: Industry leaders call for AI and sustain...

The 24th IDMA Pharmaceutical Analysts’ Conference (PAC) commenced on December 1...

Odisha Pharma Summit 2025 positions Odisha as eastern I...

“Odisha will be a leading destination for pharmaceutical and medical‑device inv...

LEO Pharma applies to EMA to expand Anzupgo use to adol...

The expansion is targeted at individuals for whom topical corticosteroids are no...

SK Capital Partners supports Swixx BioPharma’s global e...

The investment values Swixx at more than €1.5bn ($1.76bn). Swixx operates as a c...

The role of cold-chain-ready, in-city warehousing in st...

Adarsh Padmanabha highlights how cold-chain-ready, in-city warehousing is resha...

Biologics X 3DCC Conference 2026 to take place in Goa; ...

Unified summit to bring biologics and 3D cell culture communities on a single p...

Affordable ORS for all: Industry’s imperative to align ...

Mahesh Patil explains why the pharmaceutical industry must realign ORS formulat...

Sobi buys Arthrosi to expand gout treatment pipeline

Sobi will purchase for Arthrosi Skr9.1bn ($950m) in cash. Additional payments of...

FDA approves Acadia’s Daybue Stix for Rett syndrome

Rett syndrome is a rare neurodevelopmental disorder that progresses through four...

ICMR funds new clinical trial IPIROC by KOLGOTRG

Lancet publication and ovarian cancer trial discussed at Kolkata meeting The po...

Akums launches Gabapentin ER for postherpetic neuralgia...

DCGI-approved extended-release formulation introduced for once-daily dosing in ...

Odisha to host state – level pharma summit in Bhubanesw...

State government to launch pharma and medical devices policy and announce indu...

Biocon launches liraglutide for diabetes and obesity in...

The products are marketed as Diavorin and Vobexoryn through Pharmamedic B.V. T...

Zealand Pharma and OTR to develop metabolic disease the...

The multi-programme partnership leverages Zealand Pharma’s experience in obesity...